How Lila Sciences’ AI and Automated Labs Help Scientists Discover New Medicines Faster
Lila Sciences combines AI reasoning agents with autonomous robotic labs to accelerate drug discovery
“Scientists can imagine far more experiments than they can carry out.”
Lila Sciences unveiled an AI-driven autonomous laboratory platform called Iris, built on NVIDIA Nemotron and BioNeMo, that combines scientific reasoning agents with robotic wet labs to run iterative drug discovery cycles. The system narrows candidates through millions of virtual experiments before physical testing, closing the loop between computational and physical science. This represents a concrete industrial deployment of agentic AI in life sciences, a fast-growing area of AI conference buzz.